Skip to main content
SMS Pharmaceuticals Ltd logo

SMS Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · SMSPHARMA ISIN · INE812G01025 LEI · 335800XXEADQCB7GJ514 BSE.NS Manufacturing
Open in API
Filings indexed 749 across all filing types
Latest filing 2020-07-03 Regulatory Filings
Country IN India
Listing BSE.NS SMSPHARMA

About SMS Pharmaceuticals Ltd

https://smspharma.com/

SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.

Recent filings

Filing Released Lang Actions
Related Party Transactions
Regulatory Filings Classification · 90% confidence The document text is very short (1437 characters) and contains tabular data related to transactions with related parties, including key management personnel remuneration and transactions with associate companies and enterprises with significant influence. There is no indication of a full financial report, audit report, or detailed management discussion. The content resembles disclosures typically found in notes to financial statements or related party transaction disclosures, but the document itself is not a full report. It also does not appear to be an announcement or a certification. Given the nature and length, and lack of a specific report title or period, this fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2020-07-03 English
Updates
Regulatory Filings
2020-06-30 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (69 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2020-06-30 English
Updates
Regulatory Filings
2020-06-25 English
Updates
Regulatory Filings
2020-06-25 English
Updates
Regulatory Filings
2020-06-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.